Axsome Therapeutics
AXSM
AXSM
65 hedge funds and large institutions have $216M invested in Axsome Therapeutics in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
86% more funds holding
Funds holding: 35 → 65 (+30)
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
31.69% more ownership
Funds ownership: 12.84% → 44.53% (+32%)
Holders
65
Holding in Top 10
2
Calls
$25.4M
Puts
$8.8M
Top Buyers
| 1 | +$46.9M | |
| 2 | +$17.1M | |
| 3 | +$15.2M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$14.9M |
| 5 |
RI
RTW Investments
New York
|
+$8.48M |
Top Sellers
| 1 | -$4.81M | |
| 2 | -$2.23M | |
| 3 | -$2.13M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$705K |
| 5 |
Mariner
Overland Park,
Kansas
|
-$284K |